Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(16 sites)

France

Chu Besancon, Besançon

Institut Bergonie, Bordeaux

Centre Georges Francois Leclerc, Dijon

Centre Oscar Lambret, Lille

Centre Leon Berard, Lyon

Hopital de La Timone, Marseille

Icm Val D'Aurelle, Montpellier

Hotel Dieu Nantes, Nantes

Institut Curie, Paris

Hôpital COCHIN, Paris

Ico Rene Gauducheau, Saint-Herblain

Chu Saint-Etienne, Saint-Priest-en-Jarez

CHRU Hôpital Hautepierre, Strasbourg

ICANS, Strasbourg

Iuct Oncopole, Toulouse

Institut Gustave Roussy, Villejuif